Freed Vulnerable to Bundled Platforms

Diving deeper into

Freed

Company Report
Both can introduce documentation tools to clinicians already using their platforms, reducing the need to adopt and pay for a separate application.
Analyzed 9 sources

Bundling turns documentation from a paid standalone purchase into an add on inside a tool the clinician already opens every day. Freed sells note capture to individual clinicians for $99 per month, but Doximity can surface a free scribe inside Dialer, Ask, and its desktop app, while OpenEvidence can add Visits onto a medical search product already used by a large share of U.S. physicians. Epic comes from the opposite direction, placing AI Charting inside the record where the note already lives.1 2 3 4 5 6

  • Freed wins when a solo doctor or small clinic is willing to add one more app to save hours on notes. That bottom up motion helped it reach $19M ARR in March 2025 and 17,000 clinicians, but it is most exposed when rivals make note generation free and easier to try than a new subscription.1 2 3
  • Doximity has an unusually strong bundle because the workflow is already there. A clinician can place a patient call in Dialer, turn on Scribe during the call or visit, ask follow up questions in Ask, then paste the finished note into the EHR, all inside the same free clinical AI suite.4 7 8 9
  • Epic pressures the market higher up. In larger health systems, the buyer is usually the CIO or operations leader, not the doctor, and those teams prefer tools built into the EHR. Epic now markets AI Charting as part of its own platform, which narrows the room for a separate vendor to land just on documentation.3 5 6

The category is moving toward platforms that use scribing as the first free feature, then expand into coding, chart prep, patient communication, and billing. That shift favors companies with existing clinician attention or control of the patient record, and pushes standalone scribes like Freed to build a broader workflow bundle of their own.2 3 5 6